MAPT and tauopathy: Pharmacological inhibition of ROCKs decreases tau phosphorylation in cellular models of tauopathy [9], and ROCK inhibitors represent a viable therapeutic route for reducing the pathogenic forms of tau protein in tauopathies [12].